 500 Million Upfront Payment to Activate the Partnership for Ivonescimab Menlo Park, California, US, and Grand Cayman, Cayman Islands, Dec. 06, 2022 GLOBE NEWSWIRE Summit Therapeutics Inc. NASDAQ: SMMT Summit, we, or the Company today announced a definitive agreement of its partnership with Akeso Inc. HKEX Code: 9926.HK, Akeso, to in-license its breakthrough bispecific ... The post Summit Therapeutics Partners with Akeso Inc. in Deal for Up to 5 Billion to In-License Breakthro... 